From the first launch to ongoing market access operational execution, IntegriChain solves some of the most complex and pressing challenges associated with drug commercialization. We deliver pharma’s only comprehensive data, consulting, and business process platform for market access departments, providing the strategy, data, applications, and infrastructure for therapy commercialization.
Solutions overview
IntegriChain delivers the pharmaceutical industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, and managed services to power their operations and harness the value of their channel, patient and payer data.
View all products
IntegriChain provides a complete set of professional services for commercialization and market access execution–from life science strategy and operational consulting to implementation, integration, migrations, and analytics.
Services overview
We help all stakeholders in the pharmaceutical industry drive access with our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts & pricing, gross-to-net, channel, and patient services – to unlock strategic payer, provider, pharmacy and patient access insights.
Learn more about our company
Learn more about joining our growing IntegriChain team of data scientists, market access experts, analysts, and consulting professionals – our culture, our purpose, our teams in the US and Pune. Check out our careers or keep in touch for future opportunities.
Careers overview
May 6, 2017
Philadelphia, PA, May 4, 2017 –PharmaMetrics, an IntegriChain company and leading provider analytics and services to optimizing market access, today announced it has successfully completed a Service Organization Controls (SOC 1) examination of its system of controls for calculating manufacturer rebate payments. CliftonLarsonAllen LLP performed the SOC 1 examination of PharmaMetrics following The American Institute of Certified Public Accountants (AICPA) Trust Services Principles and related criteria covering security, availability, and processing integrity.
About PharmaMetrics PharmaMetrics is a leading provider of contract analytics, advisory services, and contract management outsourcing for managed markets and contracts and pricing teams at leading and emerging bio/pharma companies to optimize market access. PharmaMetrics is rated first in Contract Operations Service and first in Contract Effectiveness (Analytics) by Zensights, a leader in insights into critical biopharma vendor/supplier engagement issues and “Best in Class” vendor identification. Utilizing its deep expertise, the company delivers a market access platform comprising contract analytics, advisory services, and contract management outsourcing focused on driving optimal price, compliance, and operational efficiency. Specializing in payer and deal analysis, guidelines and processes guidance, and contract and rebate management, PharmaMetrics allows bio/pharma companies to scale their payer analytics and contracting functions to meet today’s complex commercial and government market access challenges. For more information, visit https://www.pharmametricsinc.com/.
About IntegriChain IntegriChain is a rapidly growing healthcare technology company, offering the leading cloud for enriched data and analytics to optimize distribution, patient access, and market access for life sciences managed markets teams. Pharmaceutical, biopharm/specialty pharma, generics, and medtech suppliers leverage insights from IntegriChain’s unmatched factory-to-patient visibility to maximize patient access and to address critical risks throughout the patient journey and product life cycle. IntegriChain delivers the enriched data and analytics foundation for more efficient and service-oriented channel models for mature product categories as well as for innovative products that must balance significant therapeutic benefit with out-of-pocket costs and benefit hurdles. Today IntegriChain is the trusted partner for all top-10 bio/pharmaceutical companies, 17 of the top-20 life science companies, and more than 50 other suppliers, totaling more than $250 billion in annual US commerce. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. For more information, visit www.integrichain.com and our blog, and follow us on Twitter @IntegriChain and LinkedIn.
PharmaMetrics is a registered trademark of PharmaMetrics, Inc. IntegriChain is a registered trademark of IntegriChain Incorporated. All other trademarks are property of their respective owners.
Contact Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com
Save the date!
Webinars & Resources
See List
